Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OTX-TKI in Non-Proliferative Diabetic Retinopathy
NCT07235085Phase 3Recruiting
- Sponsor
- Ocular Therapeutix
- Start
- Nov 2025
- Primary completion
- Mar 2027
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of axitinib intravitreal implant, sponsored by Ocular Therapeutix. Started Nov 2025; status: recruiting.
02
Drugs
axitinib intravitreal implant
Beyond the preview
Go deeper on NCT07235085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07235085.